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The Drosophila mutant methuselah (mth) was identified from a
screen for single gene mutations that extended average lifespan.
Mth mutants have a 35% increase in average lifespan and in-
creased resistance to several forms of stress, including heat, star-
vation, and oxidative damage. The protein affected by this muta-
tion is related to G protein-coupled receptors of the secretin
receptor family. Mth, like secretin receptor family members, has a
large N-terminal ectodomain, which may constitute the ligand
binding site. Here we report the 2.3-Å resolution crystal structure
of the Mth extracellular region, revealing a folding topology in
which three primarily b-structure-containing domains meet to
form a shallow interdomain groove containing a solvent-exposed
tryptophan that may represent a ligand binding site. The Mth
structure is analyzed in relation to predicted Mth homologs and
potential ligand binding features.
The sequence of the protein affected by the methuselah(mth) mutation predicts that it contains a 195-residue
extracellular domain followed by seven transmembrane do-
mains related to the membrane domains of G protein-coupled
receptors (GPCRs) (1). GPCRs are key transducers of bio-
logical signals, and the critical roles they play in eukaryotic
organisms are ref lected in the diverse range of ligands that
signal through GPCRs, including small molecules, peptides,
proteins, and light (2). The membrane domains of Mth and
Mth relatives identified in the Drosophila genome (3) are most
closely related to membrane regions of the B family of GPCRs
(also known as family-2 GPCRs), which includes peptide
hormone receptors that transduce signals via activation of
heterotrimeric G proteins (see Fig. 4, which is published as
supplemental material on the PNAS web site, www.pnas.org).
Phylogenetic analysis places Mth-related proteins in a separate
subgroup of GPCR family B (Fig. 1A). Family B also includes
GPCR-like proteins containing extracellular epidermal
growth factor-like modules, Ig superfamily domains, or cad-
herin domains (cell adhesion family; Fig. 1 A) (4).
GPCR family B members that have been experimentally
characterized fall into two categories: (i) those that bind and
transmit signals from peptides (e.g., secretin, insect diuretic
hormone, calcitonin), and (ii) those that appear to have cell
adhesion roles (CD97 and Flamingo) (4). In both cases, the
extracellular domains of these receptors have been implicated
in their function, either providing hormone ligand specificity
or facilitating cell adhesion (e.g., the cadherin domains in
Flamingo). Although the ectodomains of both the hormone
receptor GPCRs and Mth proteins show some similarities in
that they are about the same size and each contain their own
pattern of conserved cysteines, the Mth extracellular domain
does not share significant sequence similarity to any GPCR
family B members or other known proteins. Because the Mth
ectodomain does not include the multidomain stalk structure
common to the GPCRs with known cell adhesion roles (Fla-
mingo, CD97), a cell adhesion function seems unlikely. In-
stead, the Mth ectodomain could represent a ligand binding
region, by analogy to several hormone receptor GPCRs whose
isolated ectodomains can function in ligand binding. For
example, recombinant forms of the ectodomains of the secre-
tin receptor (5), the glucagon-like peptide-1 receptor (6), and
the pituitary adenylate cyclase activating peptide receptor (7)
form high-affinity peptide hormone binding sites andyor in-
hibit activation of the full-length form of the corresponding
receptor.
As a first step in characterizing the potential ligand binding
properties of Mth and in understanding the role of Mth and its
relatives in affecting aging and stress resistance, we solved the
crystal structure of the Mth ectodomain. The structure reveals
a folding topology likely to be conserved in Mth-related proteins
and a potential ligand binding site.
Materials and Methods
Protein Expression and Purification. A construct encoding a soluble
portion of Mth (including the Mth signal sequence and residues
1–195 of the mature protein) with a C-terminal His tag was
subcloned into the baculovirus transfer vector pVL1392
(PharMingen). Mth was purified from supernatants of baculo-
virus-infected High 5 cells, buffer exchanged to 50 mM phos-
phate at pH 8.0, followed by Ni-NTA chromatography
(Ni-NTA superflow, Qiagen, Chatsworth, CA). Protein from an
imidazole elution was further purified by gel filtration chroma-
tography. NH2-terminal protein sequencing yielded the
sequence DILEXDYFDTV.
Crystallization and Data Collection. Crystals (space group P212121,
a 5 68.9 Å, b 5 73.0 Å, c 5 115.1 Å; two molecules per
asymmetric unit) of Mth were grown at 22°C in hanging drops
by combining 4 ml of protein solution [Mth (20 mgyml) and 20
mM Tris at pH 7.4] with 2 ml of precipitant solution (1.6 M
Li2SO4 and 0.1 M Hepes at pH 7.5). Before data collection,
crystals were transferred to a cryoprotectant solution (1.6 M
Li2SO4, 0.1 M Hepes at pH 7.5, and 12.5% glycerol). Initial
native data to 2.6 Å were collected at 2150°C from a single
crystal at Stanford Synchrotron Radiation Laboratory (SSRL,
Stanford, CA) beamline 7–1. A selenomethionine derivative
data set was collected at SSRL beamline 9–2. A multiwavelength
anomalous dispersion (MAD) data set to 2.3 Å was collected on
the lead derivative at Brookhaven beamline X8C.
Structure Determination, Phasing, and Refinement. Data were pro-
cessed and scaled with DENZO and SCALEPACK (8). Heavy atom
refinement of four lead and four gadolinium sites was done with
SHARP (9), yielding phases to 3.0 Å with a mean figure of merit
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of 0.43. A solvent-f lattened map calculated from multiple iso-
morphous replacement including anomalous scattering phases
was skeletonized and used to calculate a noncrystallographic
symmetry (NCS) operator. A 3.0-Å NCS-averaged, solvent-
f lattened map was used for initial model building with O (10).
Map interpretation was aided by a native anomalous Fourier
map to locate disulfides and an anomalous Fourier by using the
selenomethionine derivative to locate the four methionine res-
idues. Refinement was carried out on the lead l1 dataset
(‘‘native’’ II) in place of the native data (native I) by using the
simulated annealing and minimization protocols in CNS (11) with
bulk solvent and anisotropy corrections, refinement of individual
B factors, and tight NCS restraints (200 kcalymolz Å2). The NCS
operator was broken into two operators covering D1 (residues
1–41 and 55–63) and D2D3 (residues 86–185). The model
includes residues 1–188, four lead atoms, disulfide bonds be-
tween cysteine residues 5 and 59, 61 and 66, 70 and 164, 71 and
82, and 126 and 185, and ordered N-linked carbohydrates
attached to Asn-21, Asn-99, and Asn-146. Ramachandran plot
statistics are as defined by PROCHECK (12). Figures were made
with MOLSCRIPT (13) and RASTER-3D (14).
To verify the structural difference between NCS molecules,
the final model was subjected to simulated annealing and
refinement with a single NCS operator. Both Rcryst and Rfree were
0.8% higher with a single NCS operator instead of two operators.
The NCS-related regions are very similar (rms deviations of 0.04
Å for D1 and 0.06 Å for D2D3). When the two molecules are
aligned by using the D2D3 NCS operator, the D1 domains have
an rms deviation of 1.1 Å.
Fig. 1. Relation of Mth to family B GPCRs and other Mth homologs. (A) Phylogenetic relationship of transmembrane regions of GPCR family B proteins. A
phylogenetic tree was generated by using the neighbor-joining method based on an alignment of transmembrane domains generated with the CLUSTALW
program (25). The human b-2 adrenergic receptor (not shown) served as the outgroup. A subfamily consisting of ’10 Mth-like proteins identified from the
Drosophila genome project clusters with Mth. CIRL, calcium-independent receptor of a-latrotoxin; BAI-1, brain-specific angiogenesis inhibitor 1; HE6, human
epididymal gene product 6; SECR, secretin receptor; VIPR, vasoactive intestinal peptide receptor; PTRR, parathyroid hormone-related peptide receptor; GIPR,
gastric inhibitory peptide receptor; GLUCR, glucagon receptor; CALR, calcitonin receptor. (B) Sequence alignment of the Mth ectodomain with predicted
homologs from the Drosophila genome. Residue numbering begins at the first residue of the mature protein. Crystallographically determined secondary-
structural elements are shown above the sequences. The 10 cysteines that form five disulfide bonds in the Mth ectodomain are highlighted in yellow, and
potential N-linked glycosylation sites are highlighted in cyan.
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Analysis of Mth Homologs. The predicted homologs Mth-like 1 and
Mth-like 5 possess significant sequence similarity to Mth only in
their transmembrane domains. One homolog, Mth-like 6, con-
sists only of a truncated form of the Mth ectodomain. We
identified two additional full-length Mth homologs in the Dro-
sophila genome: Mth-like 11 (map position 3R;86A, in GenBank
accession no. AE003687 between positions 16240 and 17991)
and Mth-like 12 (map position 3R;87E, in GenBank accession
no. AE003699 between positions 207030 and 208827). The
transmembrane regions of Mth-like 3 and Mth-like 4 were not
included in the first release of predicted protein sequences from
the Drosophila genome (3) and were added to Fig. 1B after
manual inspection revealed additional exons with homology to
the Mth transmembrane region.
Results and Discussion
Overall Structure and Domain Organization. The Mth ectodomain
was expressed with a baculovirus expression system and purified
from the supernatants of infected insect cells. The crystal
structure was determined to 2.3 Å by multiple isomorphous
replacement including anomalous scattering and MAD (Tables
1 and 2). The Mth ectodomain has a relatively compact, b-sheet-
rich fold with five disulfide bonds (Fig. 2) that does not closely
resemble that of any protein of known structure [i.e., no similar
folds were found by using the DALI (15) or VAST (16) database
search programs]. The structure can be divided into three
domains. The first domain (D1; residues 1–60) and third domain
(D3; residues 123–188) share a similar fold consisting of two
three-stranded b-sheets, whereas the middle domain (D2, resi-
dues 61–122), which contains three two-stranded b-sheets and a
short a-helix, wraps around the third domain to form a super-
domain (D2D3). There are no backbone hydrogen bonds be-
tween D1 and the rest of the protein and the buried surface area
between D1 and D2D3 [1,460 Å2, calculated with CNS (11) using
a 1.4-Å probe radius] is significantly smaller than that between
D3 and D1-D2 (2,750 Å2), consistent with the assignment of
D2D3 as a superdomain. Comparison of the two Mth ectodo-
mains in the crystallographic asymmetric unit cell suggests the
potential for flexibility at the interface between D1 and the
D2D3 superdomain. A small, but measurable, difference is
observed between the relative positions of the D1 and D2D3
domains in the two Mth ectodomains. The structural difference
is verified by an improvement in the crystallographic R factors
when the interdomain angle is allowed to vary compared with
when the two Mth molecules are restrained to the same domain
arrangement during refinement. The flexibility between D1 and
D2D3 raises the possibility that ligand binding induces a similar
conformational change, which may be relevant for the signaling
mechanism of this receptor.
The D3 portion of the D2D3 superdomain shares a similar
folding topology and several common structural features with
D1 (Fig. 2B). First, each domain includes two disulfide-linked
cysteines at analogous positions (Cys-5 and Cys-59 in D1 and
Cys-126 and Cys-185 in D3) that connect the beginning and end
of each domain. Second, two of the five potential N-linked
glycosylation sites occur at corresponding positions in D1 and D3
(Asn-21 and Asn-146) and ordered carbohydrate is visible at
both sites. Although D1 and D3 share these structural features,
they are related by ,10% sequence identity (based on a struc-
ture-based sequence alignment) and superimpose well only over
the S2-S3-S4 sheet (29 of 62 residues align with an rms deviation
of 1.32 Å calculated with a 3.8-Å cutoff distance) (Fig. 2C). One
significant difference between D1 and D3 is that the long S5-S6
b-stand pair in D3 is broken into two segments in D1 (near
residues 40 and 53), which causes these strands to bend in such
a way as to make contact with the D2D3 superdomain.
Potential Ligand Binding Site. Between the D1 and D2D3 domains
is a shallow groove containing a solvent exposed tryptophan,
Trp-120, the only tryptophan residue in the Mth ectodomain
(Fig. 3A). Receptor-ligand interfaces often bury otherwise ex-
posed hydrophobic side chains, which contribute much of the
free energy of binding (see discussion and references cited in ref.
17). For example, solvent exposed tryptophans in FcRn and HFE
are critical for their interactions with binding partners (17, 18).
Table 1. Data collection and heavy-atom phasing for Mth
Data set l (Å) Resolution (Å) Complete (%)* Rmerge† (%) IysI rms fhyE‡
Native I 1.54 2.6 100.0 (99.9) 5.6 (34.1) 23.6 (3.5)
Pb(CH3)3OAc 1.54 2.8 98.8 (93.0) 6.9 (46.3) 13.3 (2.4) 1.4
GdCl3 1.54 3.4 98.9 (99.5) 13.0 (43.4) 6.5 (1.8) 0.9
SeMet 0.979 2.3 99.4 (99.9) 7.7 (32.8) 20.9 (4.2) N.D.
Pb(CH3)3OAc MAD data
l1 peakyNat. II 0.9490 2.3 99.5 (98.6) 6.9 (33.8) 15.5 (2.8) 2.3
l2 inflection 0.9504 2.3 99.5 (99.3) 6.7 (36.8) 15.5 (2.6) 1.9
l3 remote 0.8610 2.3 98.1 (95.3) 6.8 (41.5) 13.4 (2.1) 2.1
*Complete represents (number of independent reflections)ytotal theoretical number.
†Rmerge (I) 5 [SuI(i) 2 ^I(h)& uySI(i)], where I(i) is the ith observation of the intensity of the hkl reflection and ^I& is the mean intensity from multiple measurements
of the hkl reflection.
‡rms fhyE represents phasing power, where fh is the heavy-atom structure factor amplitude and E is the residual lack of closure error.
Table 2. Refinement statistics for Mth
Resolution (Å) 20.0–2.3
Theoretical refl. in resol. range 26,430
Reflections in working set uFu . 0 25,022
Reflections in test set uFu . 0 1,283 (5%)
Rfree (%)* 22.7
Rcryst (%)† 21.2
rms deviations from ideality
Bond lengths (Å) 0.008
Bond angles (deg) 1.40
Number of nonhydrogen atoms:
Protein 3,058
Water 201
Carbohydrate 98
Pb and sulfate 14
Ramachandran plot
Most favored (%) 88.5
Additional allowed (%) 11.2
Generously allowed (%) 0.3
Disallowed (%) 0.0
*Rfree is calculated over reflections in a test set not included in atomic
refinement.
†Rcryst (F) 5 Sh iFobs(h)u 2 uFcalc(h)iyShuFobs(h)u, where uFobs(h)u and uFcalc(h)u are the
observed and calculated structure factor amplitudes for the hkl reflection.
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Hence, the region near Mth Trp-120 may be suitable for binding
a protein or peptide ligand or a hydrophobic small molecule.
Localization of a ligand binding site in an interdomain groove
also is not unprecedented: for example, the ligand binding
domain of the ionotropic glutamate receptor, also a bilobed
protein that bears a superficial resemblance to the Mth ectodo-
main structure, includes a shallow groove that serves as the
ligand binding site (19).
Ten homologs of Mth have been predicted from the Drosoph-
ila genome (3, 20). Most of these are organized in the same
manner as Mth: an NH2-terminal ectodomain followed by a
seven-pass transmembrane domain. The NH2-terminal domains
of the Mth-related proteins share between 27% and 65%
sequence identity with the Mth ectodomain, suggesting that they
will fold into similar tertiary structures. The 10 cysteines that
form five disulfide bonds in Mth are conserved in all but one Mth
homolog (Mth-like 3, in which a leucine substitutes for the
cysteine in the strand S5 region of D3). Several of the N-linked
carbohydrate sites also are conserved in many of the Mth-related
proteins, particularly the analogous sites in D1 and D3 located
between strands S2 and S3. In Fig. 3B, the noncysteine residues
that are well-conserved (present in at least 70% of the Mth
homologs) are highlighted on the structure of the Mth ectodo-
main. A majority of these residues are in D1, likely reflecting the
greater constraints required to maintain the fold of this small
domain. In addition, some of the interdomain interactions that
stabilize the Mth fold are conserved in the Mth homologs. For
example, conserved residues (D2 Asp-121, D1 His-55, and D1
Thr-36) surround and form hydrogen bonds to D1 Arg-57. The
interaction between the side chains of Arg-57 and Asp-121 is one
of the most significant between D1 and D2D3 (Fig. 3 B and C),
and conservation of this interaction suggests that D1 and D2D2
will have a common arrangement in the Mth homologs. Trp-120
is conserved in only one of the Mth homologs (Mth-like 2) (Fig.
1B), thus the proposal that this residue forms part of the ligand
binding site implies that the Mth homologs bind different
ligands.
In addition to a ligand interaction surface, another region of
the Mth ectodomain that may be functionally important is the
region contacting the extracellular face of the seven-pass trans-
membrane domain, potentially in such a way as to signal ligand
binding. In the recently determined crystal structure of the
GPCR rhodopsin (21), the extracellular NH2-terminal region
(residues 1–35) makes contact with all three of the extracellular
Fig. 2. Structure of the Mth ectodomain. (A) Ribbon diagram of the Mth structure (D1, red; D2, green; D3, blue). Ordered N-linked carbohydrates are shown
in cyan in ball-and-stick representation and disulfide bonds are yellow. (B) (Upper) Topology diagrams for three extracellular domains of Mth. Potential N-linked
glycosylation sites are labeled CHO, with parentheses denoting N-linked sites in which ordered carbohydrates were not observed. (Lower) Ribbon diagrams of
the three domains of Mth. A disulfide bond (yellow) and an N-linked carbohydrate (cyan) are located at corresponding positions in D1 and D3. (C) Stereoview
of a superposition of D1 (in red) and D3 (in blue) made by aligning the Ca atoms of the S2-S3-S4 b-sheet.
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interhelical loops, thus the Mth ectodomain also may contact
loops between transmembrane helices. Because there are only
seven residues between the C terminus of the Mth ectodomain
observed in the structure and the predicted beginning of the first
hydrophobic transmembrane region, the region near the Mth
ectodomain C terminus has the potential to interact with loop
regions between the transmembrane regions. There are three
loops in this region: between strands S3 and S4 in D3 (including
Phe-153 and conserved residue Asp-154), between S59 and S69
in D1 (including conserved residue Asp-46), and preceding S1 in
D3 (around Gly-128) (Fig. 3D). The occurrence of conserved
residues within these loops suggests that these regions may be
involved in positioning the ectodomain on the transmembrane
region andyor signaling ligand binding to the transmembrane
region. When the region of Mth containing these loops and the
C terminus of the Mth ectodomain is oriented on a model of the
seven-pass transmembrane portion, the ectodomain is posi-
tioned such that the interdomain cleft containing Trp-120 is
Fig. 3. Possible ligand binding site on Mth. (A) Stereoview of a space-filling model of Mth showing the shallow groove between D1 and D2D3. Atoms are colored
according to their temperature factor, with blue and red corresponding to low (relatively well-ordered) and high temperature factors, respectively. Trp-120
(yellow), suggested to be at a ligand binding surface (see text), has a solvent accessible surface area of 126 Å2 [calculated by using a 1.4-Å probe radius with
AREAIMOL (26)] compared with 238 Å2 for a fully exposed tryptophan. Examples of protein–protein complexes including critical tryptophan residues at the
interface include HFEytransferrin receptor (HFE Trp-81; 115 Å2; second most exposed tryptophan in HFE) (27) and FcRnyFc (FcRn Trp-133; 136 Å2; third most
exposed tryptophan in FcRn) (17). Other receptor-ligand interfaces that include surface-exposed hydrophobic side chains on one of the binding partners are
discussed in ref. 17 and references therein. (B) Stereoview of Mth showing residues that are greater than 70% conserved in known Drosophila Mth homologs
(excluding conserved cysteines). Asp-121 (conserved in five of the Mth-like proteins and conservatively substituted for glutamate in three others) is involved in
an interdomain hydrogen bonds (purple dotted lines) with Arg-57 (conserved in all Mth homologs). (C) Experimental electron density map (MAD solvent-
flattened map contoured at 2 s) in the region near Trp-120. (D) Model for the structure of intact Mth showing relative sizes of Mth ectodomain and the
transmembrane region. The Mth transmembrane region is represented by the structure of rhodopsin (21), with adjustments in loop regions to reflect differences
in loop lengths between rhodopsin and Mth. Dashed lines represent the seven residues following the Mth ectodomain C terminus and the predicted start of the
first transmembrane helix. The Mth ectodomain is oriented such that the C terminus of the model derived from the crystal structure is closest to the membrane.
In this orientation, the interdomain groove and Trp-120 are accessible for ligand binding, and two regions containing residues (Asp-46 and Phe-153) suggested
to interact with the extracellular face of the seven pass transmembrane domain are positioned near the interhelical loops.
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oriented away from the membrane, consistent with the sugges-
tion that it represents a ligand binding site (Fig. 3D).
Conclusions
The structure of the Mth ectodomain represents one of only a
few available three-dimensional structures of GPCRs. Previous
structural studies of GPCRs include the 2.8-Å crystal structure
of rhodopsin (21), and NMR structures of the NH2 terminus
(residues 1–47) of the cholecystokinin A receptor (22) and a
31-aa fragment of the extracellular domain of the parathyroid
hormone receptor (23). There is no structural similarity of these
extracellular domains to each other or to the Mth ectodomain.
Further structural studies of GPCRs, combined with the struc-
tural characterizations of heterotrimeric G protein complexes
(24), will facilitate obtaining a complete picture of the molecular
events leading from ligand binding to G protein activation.
Note Added in Proof. Also recently reported was the crystal structure of
the extracellular domain of the metabotropic glutamate receptor (28).
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